Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
2928 Stock Overview
RIZAP GROUP, Inc. engages in beauty, health, and lifestyle related businesses in Japan.
RIZAP GROUP Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥149.00 |
52 Week High | JP¥203.00 |
52 Week Low | JP¥129.00 |
Beta | 1.46 |
1 Month Change | 1.36% |
3 Month Change | 1.36% |
1 Year Change | -18.13% |
3 Year Change | -49.49% |
5 Year Change | -68.25% |
Change since IPO | 626.83% |
Recent News & Updates
Shareholder Returns
2928 | JP Personal Products | JP Market | |
---|---|---|---|
7D | 2.8% | 1.2% | 0.5% |
1Y | -18.1% | -18.1% | -0.09% |
Return vs Industry: 2928 matched the JP Personal Products industry which returned -18.1% over the past year.
Return vs Market: 2928 underperformed the JP Market which returned -0.1% over the past year.
Price Volatility
2928 volatility | |
---|---|
2928 Average Weekly Movement | 3.0% |
Personal Products Industry Average Movement | 4.4% |
Market Average Movement | 3.9% |
10% most volatile stocks in JP Market | 8.1% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 2928 is not significantly more volatile than the rest of JP stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 2928's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 5,034 | Takeshi Seto | https://www.rizapgroup.com |
RIZAP GROUP, Inc. engages in beauty, health, and lifestyle related businesses in Japan. It is also involved in the body makeup business; production, wholesale, and retail business of interior goods; sales of cosmetics, beauty equipment, and health food; maternity/baby related business; franchise business for various miscellaneous goods; bag planning/manufacturing; wholesale and retail of recording media, mobile phone, music video software, audio-video related miscellaneous goods, etc.; and book, magazine, and newspaper publication businesses. In addition, the company provides medical institution consulting, marketing support, and medical peripheral services; contact, mailing, and logistics services; printing agency and multimedia advertising services; general commercial printing and special printing services; processes and sells electrical parts; produces and sells various packaging materials and display backlight condensers; and plans and sells sports equipment, such as soccer, futsal, athletics, running, basketball, rugby, baseball equipment, etc. Further, it engages in fitness, cafe, childcare, and soccer club management; wholesale of Japanese clothing, women's clothing, etc.; designing, manufacturing, and wholesale of twisted yarn; watch import and wholesale; real estate/general construction; internet mail order, general merchandise OEM, and production management businesses, as well as operates specialty chain stores that sells casual wear and miscellaneous goods.
RIZAP GROUP Fundamentals Summary
2928 fundamental statistics | |
---|---|
Market Cap | JP¥82.88b |
Earnings (TTM) | JP¥2.10b |
Revenue (TTM) | JP¥162.36b |
39.4x
P/E Ratio0.5x
P/S RatioIs 2928 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2928 income statement (TTM) | |
---|---|
Revenue | JP¥162.36b |
Cost of Revenue | JP¥86.91b |
Gross Profit | JP¥75.45b |
Other Expenses | JP¥73.35b |
Earnings | JP¥2.10b |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 3.78 |
Gross Margin | 46.47% |
Net Profit Margin | 1.29% |
Debt/Equity Ratio | 88.6% |
How did 2928 perform over the long term?
See historical performance and comparisonValuation
Is 2928 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2928?
Other financial metrics that can be useful for relative valuation.
What is 2928's n/a Ratio? | |
---|---|
n/a Ratio | 0x |
n/a | n/a |
Market Cap | JP¥82.88b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.8x |
Enterprise Value/EBITDA | 8.6x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 2928's PE Ratio compare to its peers?
2928 PE Ratio vs Peers |
---|
Company | PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 44.8x | ||
4917 Mandom | 125.1x | 53.7% | JP¥70.3b |
7806 MTG | 11.5x | 10.4% | JP¥52.0b |
6630 Ya-Man | 15.7x | 10.7% | JP¥87.9b |
4933 I-ne | 26.9x | 15.3% | JP¥40.8b |
2928 RIZAP GROUP | 39.4x | n/a | JP¥82.9b |
Price-To-Earnings vs Peers: 2928 is good value based on its Price-To-Earnings Ratio (39.4x) compared to the peer average (44.8x).
Price to Earnings Ratio vs Industry
How does 2928's PE Ratio compare vs other companies in the JP Personal Products Industry?
Price-To-Earnings vs Industry: 2928 is expensive based on its Price-To-Earnings Ratio (39.4x) compared to the JP Personal Products industry average (22.9x)
Price to Earnings Ratio vs Fair Ratio
What is 2928's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 39.4x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 2928's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 2928 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 2928 (¥149) is trading above our estimate of fair value (¥141.78)
Significantly Below Fair Value: 2928 is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Future Growth
How is RIZAP GROUP forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
12.5%
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RIZAP GROUP has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Check out RIZAP GROUP's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
Past Performance
How has RIZAP GROUP performed over the past 5 years?
Past Performance Score
4/6Past Performance Score 4/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
-23.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2928 has high quality earnings.
Growing Profit Margin: 2928's current net profit margins (1.3%) are higher than last year (0.7%).
Past Earnings Growth Analysis
Earnings Trend: 2928's earnings have declined by 23.7% per year over the past 5 years.
Accelerating Growth: 2928's earnings growth over the past year (77.4%) exceeds its 5-year average (-23.7% per year).
Earnings vs Industry: 2928 earnings growth over the past year (77.4%) exceeded the Personal Products industry 19.8%.
Return on Equity
High ROE: 2928's Return on Equity (10.1%) is considered low.
Discover strong past performing companies
Financial Health
How is RIZAP GROUP's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: 2928's short term assets (¥73.5B) exceed its short term liabilities (¥61.6B).
Long Term Liabilities: 2928's short term assets (¥73.5B) exceed its long term liabilities (¥42.1B).
Debt to Equity History and Analysis
Debt Level: 2928's net debt to equity ratio (20.5%) is considered satisfactory.
Reducing Debt: 2928's debt to equity ratio has reduced from 185% to 88.6% over the past 5 years.
Debt Coverage: 2928's debt is well covered by operating cash flow (31.3%).
Interest Coverage: 2928's interest payments on its debt are well covered by EBIT (3.4x coverage).
Balance Sheet
Discover healthy companies
Dividend
What is RIZAP GROUP current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 2928's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 2928's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 2928's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 2928's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: 2928 is not paying a notable dividend for the JP market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 2928 has not reported any payouts.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
3.6yrs
Average management tenure
CEO
Takeshi Seto (44 yo)
19.33yrs
Tenure
Mr. Takeshi Seto has been the President of RIZAP GROUP, Inc. since April 2003 which Mr. Seto established. Mr. Seto serves as President of Global Medical Research Institute Co., Ltd. He was President of Sys...
Leadership Team
Experienced Management: 2928's management team is considered experienced (3.6 years average tenure).
Board Members
Experienced Board: 2928's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
RIZAP GROUP, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: RIZAP GROUP, Inc.
- Ticker: 2928
- Exchange: SPSE
- Founded: 2003
- Industry: Personal Products
- Sector: Household
- Implied Market Cap: JP¥82.876b
- Shares outstanding: 556.22m
- Website: https://www.rizapgroup.com
Number of Employees
Location
- RIZAP GROUP, Inc.
- Shinjuku Front Tower
- 31st Floor
- Tokyo
- 169-0074
- Japan
Listings
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/08/07 00:00 |
End of Day Share Price | 2022/08/05 00:00 |
Earnings | 2022/03/31 |
Annual Earnings | 2022/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.